tirzepatide news 2025 New clinical trial: Zepbound (tirzepatide) helped adults lose an average of 20.2% of their body weight—around 50 lbs—over 72 weeks, outperforming Wegovy's 13.7% (~33 lbs). Credit to: https://www.healthline.com/health-news/zepbound-wegovy-weight-loss Tirzepatide Reduces Food Intake and

In this blog post, well explore the importance of self-testing and delve into the benefits of monitoring blood pressure and heart rate, temperature, pulse oximetry, and blood glucose levels from the comfort of your own space

Eligible patients may discuss FDA-approved Zepbound, compounded tirzepatide programs, insurance verification, and self-pay treatment options based on clinical needs and provider recommendations

If left untreated, hyperthyroidism can lead to major issues such as heart disease, bone loss, and, in severe circumstances, a life-threatening thyroid storm

Prioritise easily digestible foods such as lean proteins, cooked vegetables, and low-FODMAP options whilst avoiding high-fat meals, cruciferous vegetables, legumes, and carbonated drinks

Nor does it explain another surprising finding from the study: men taking these weight-loss treatments appeared to face three times the risk of vision loss compared to women